Kambiz Yazdi
Stock Analyst at BTIG
(4.70)
# 189
Out of 5,239 analysts
26
Total ratings
76.92%
Success rate
24.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Reiterates: Buy | $843 | $343.20 | +145.63% | 7 | May 8, 2026 | |
| RAPP Rapport Therapeutics | Reiterates: Buy | $53 | $37.22 | +42.40% | 5 | May 8, 2026 | |
| SION Sionna Therapeutics | Reiterates: Buy | $58 | $40.94 | +41.67% | 5 | Apr 27, 2026 | |
| ZVRA Zevra Therapeutics | Initiates: Buy | $23 | $11.05 | +108.14% | 1 | Mar 16, 2026 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $49 | $32.11 | +52.60% | 3 | Mar 11, 2026 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $19.94 | +15.35% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $20.69 | -8.17% | 2 | Mar 11, 2025 | |
| EYPT EyePoint | Initiates: Buy | $15 | $13.62 | +10.13% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.42 | +252.11% | 1 | Apr 12, 2024 |
Praxis Precision Medicines
May 8, 2026
Reiterates: Buy
Price Target: $843
Current: $343.20
Upside: +145.63%
Rapport Therapeutics
May 8, 2026
Reiterates: Buy
Price Target: $53
Current: $37.22
Upside: +42.40%
Sionna Therapeutics
Apr 27, 2026
Reiterates: Buy
Price Target: $58
Current: $40.94
Upside: +41.67%
Zevra Therapeutics
Mar 16, 2026
Initiates: Buy
Price Target: $23
Current: $11.05
Upside: +108.14%
vTv Therapeutics
Mar 11, 2026
Reiterates: Buy
Price Target: $49
Current: $32.11
Upside: +52.60%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $19.94
Upside: +15.35%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $20.69
Upside: -8.17%
EyePoint
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $13.62
Upside: +10.13%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.42
Upside: +252.11%